10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001564590-19-030749 |
| Period End Date | 20190630 |
| Filing Date | 20190808 |
| Fiscal Year | 2019 |
| Fiscal Period | Q2 |
| XBRL Instance | tmdx-20190629.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
66 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$47.24M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$20.24M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$48.99M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$3.44M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$7.11M | USD | Point-in-time |
| Inventory |
InventoryNet
|
$11.22M | USD | Point-in-time |
| Inventory |
InventoryNet
|
$9.28M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.84M | USD | Point-in-time |
| Common Stock, Par or Stated Value Per Share |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.57M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$116.13M | USD | Point-in-time |
| Common Stock, No Par Value |
CommonStockNoParValue
|
- | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$34.79M | USD | Point-in-time |
| Common Stock, Shares Authorized |
CommonStockSharesAuthorized
|
60.00M | shares | Point-in-time |
| Common Stock, Shares Authorized |
CommonStockSharesAuthorized
|
150.00M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.38M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.47M | USD | Point-in-time |
| Common Stock, Shares, Issued |
CommonStockSharesIssued
|
1.40M | shares | Point-in-time |
| Common Stock, Shares, Issued |
CommonStockSharesIssued
|
21.10M | shares | Point-in-time |
| Deferred offering costs |
DeferredOfferingCosts
|
$3.38M | USD | Point-in-time |
| Deferred offering costs |
DeferredOfferingCosts
|
$4.40M | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$500.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$500.00K | USD | Point-in-time |
| Common Stock, Shares, Outstanding |
CommonStockSharesOutstanding
|
21.10M | shares | Point-in-time |
| Common Stock, Shares, Outstanding |
CommonStockSharesOutstanding
|
1.40M | shares | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$6.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$6.00K | USD | Point-in-time |
| Total assets |
Assets
|
$121.01M | USD | Point-in-time |
| Total assets |
Assets
|
$42.16M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$6.66M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$4.72M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilities
|
$8.18M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilities
|
$7.18M | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$306.00K | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$175.00K | USD | Point-in-time |
| Current portion of deferred rent |
DeferredRentCreditCurrent
|
$360.00K | USD | Point-in-time |
| Current portion of deferred rent |
DeferredRentCreditCurrent
|
$349.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.38M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$12.55M | USD | Point-in-time |
| Preferred stock warrant liability |
PreferredStockWarrantsAndRightsOutstanding
|
$898.00K | USD | Point-in-time |
| Long-term debt, net of discount |
LongTermDebtNoncurrent
|
$33.67M | USD | Point-in-time |
| Long-term debt, net of discount |
LongTermDebtNoncurrent
|
$33.90M | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$759.00K | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$574.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$47.88M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$49.85M | USD | Point-in-time |
| Commitments and contingencies (Note 10) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 10) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, no par value; 25,000,000 shares authorized at June 29, 2019; none issued and outstanding at June 29, 2019 |
TemporaryEquityPreferredStockCarryingAmount
|
- | USD | Point-in-time |
| Preferred stock, no par value; 25,000,000 shares authorized at June 29, 2019; none issued and outstanding at June 29, 2019 |
TemporaryEquityPreferredStockCarryingAmount
|
- | USD | Point-in-time |
| Convertible preferred stock (Series A-1, B, B-1, C, D, E and F) $0.0001 par value; 50,776,054 shares authorized at December 29, 2018; 50,404,140 shares issued and outstanding at December 29, 2018 |
TemporaryEquityCarryingAmountAttributableToParent
|
$186.52M | USD | Point-in-time |
| Common stock, no par value; 150,000,000 shares authorized, 21,098,368 shares issued and outstanding at June 29, 2019 |
CommonStockValueNoParValue
|
$423.25M | USD | Point-in-time |
| Common stock, $0.0001 par value; 60,000,000 shares authorized, 1,397,800 shares issued and 1,397,493 shares outstanding at December 29, 2018 |
CommonStockValue
|
$1.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$143.79M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-58.00K | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-101.00K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-335.94M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-352.03M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-199.04M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-168.72M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-179.66M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-192.24M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-173.59M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$71.16M | USD | Point-in-time |
| Total liabilities, convertible preferred stock and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$42.16M | USD | Point-in-time |
| Total liabilities, convertible preferred stock and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$121.01M | USD | Point-in-time |
Income Statement
66 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net revenue |
Revenues
|
$5.67M | USD | 1 Quarter |
| Net revenue |
Revenues
|
$2.92M | USD | 1 Quarter |
| Net revenue |
Revenues
|
$10.34M | USD | 2 Qtrs |
| Net revenue |
Revenues
|
$5.43M | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$4.44M | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$1.74M | USD | 1 Quarter |
| Cost of revenue |
CostOfRevenue
|
$2.33M | USD | 1 Quarter |
| Cost of revenue |
CostOfRevenue
|
$3.33M | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$5.91M | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$3.33M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$2.10M | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$1.18M | USD | 1 Quarter |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$4.79M | USD | 1 Quarter |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$6.90M | USD | 2 Qtrs |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$3.43M | USD | 1 Quarter |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$8.67M | USD | 2 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$5.14M | USD | 2 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$6.25M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$10.90M | USD | 2 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.90M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$11.04M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$12.04M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$19.57M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$6.33M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-5.16M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-7.71M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-9.94M | USD | 2 Qtrs |
| Loss from operations |
OperatingIncomeLoss
|
$-13.67M | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$2.21M | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$571.00K | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$1.11M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$313.00K | USD | 1 Quarter |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$341.00K | USD | 2 Qtrs |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$240.00K | USD | 2 Qtrs |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$210.00K | USD | 1 Quarter |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$614.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$247.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$144.00K | USD | 2 Qtrs |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-253.00K | USD | 2 Qtrs |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-428.00K | USD | 1 Quarter |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-951.00K | USD | 1 Quarter |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-1.48M | USD | 1 Quarter |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-1.06M | USD | 2 Qtrs |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-2.40M | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-16.07M | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-11.00M | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-9.19M | USD | 1 Quarter |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-6.11M | USD | 1 Quarter |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$15.00K | USD | 2 Qtrs |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$10.00K | USD | 1 Quarter |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$8.00K | USD | 1 Quarter |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$20.00K | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-6.12M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.89M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.20M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-11.02M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-4.90M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-16.09M | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, basic and diluted |
EarningsPerShareBasicAndDiluted
|
$-2.36 | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, basic and diluted |
EarningsPerShareBasicAndDiluted
|
$-2.21 | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, basic and diluted |
EarningsPerShareBasicAndDiluted
|
$-0.70 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, basic and diluted |
EarningsPerShareBasicAndDiluted
|
$-1.30 | USD | 1 Quarter |
| Weighted average common shares outstanding, basic and diluted |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
13.13M | shares | 1 Quarter |
| Weighted average common shares outstanding, basic and diluted |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7.28M | shares | 2 Qtrs |
| Weighted average common shares outstanding, basic and diluted |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4.68M | shares | 2 Qtrs |
| Weighted average common shares outstanding, basic and diluted |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4.69M | shares | 1 Quarter |
Cash Flow Statement
64 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-11.02M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-16.09M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-23.80M | USD | Annual |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$534.00K | USD | 2 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$337.00K | USD | 2 Qtrs |
| Stock-based compensation expense |
ShareBasedCompensation
|
$277.00K | USD | 2 Qtrs |
| Stock-based compensation expense |
ShareBasedCompensation
|
$61.00K | USD | 2 Qtrs |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$341.00K | USD | 2 Qtrs |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$240.00K | USD | 2 Qtrs |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$210.00K | USD | 1 Quarter |
| Change in fair value of preferred stock warrant liability |
FairValueAdjustmentOfWarrants
|
$614.00K | USD | 1 Quarter |
| Non-cash interest expense |
PaidInKindInterest
|
$48.00K | USD | 2 Qtrs |
| Non-cash interest expense |
PaidInKindInterest
|
$231.00K | USD | 2 Qtrs |
| Net amortization of premiums on marketable securities |
AmortizationOfDebtDiscountPremium
|
$-24.00K | USD | 2 Qtrs |
| Net amortization of premiums on marketable securities |
AmortizationOfDebtDiscountPremium
|
$9.00K | USD | 2 Qtrs |
| Loss on extinguishment of debt |
GainsLossesOnExtinguishmentOfDebt
|
$-305.00K | USD | 2 Qtrs |
| Unrealized foreign currency transaction (gains) losses |
ForeignCurrencyTransactionGainLossUnrealized
|
$-10.00K | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$1.82M | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$3.68M | USD | 2 Qtrs |
| Inventory |
IncreaseDecreaseInInventories
|
$2.03M | USD | 2 Qtrs |
| Inventory |
IncreaseDecreaseInInventories
|
$3.23M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$58.00K | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-259.00K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-773.00K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.44M | USD | 2 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$1.09M | USD | 2 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$816.00K | USD | 2 Qtrs |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$-130.00K | USD | 2 Qtrs |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$-37.00K | USD | 2 Qtrs |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$164.00K | USD | 2 Qtrs |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$174.00K | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-13.80M | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-19.43M | USD | 2 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$151.00K | USD | 2 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$40.00K | USD | 2 Qtrs |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$48.95M | USD | 2 Qtrs |
| Proceeds from sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$11.97M | USD | 2 Qtrs |
| Net cash (used in) provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-49.10M | USD | 2 Qtrs |
| Net cash (used in) provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$11.94M | USD | 2 Qtrs |
| Repayments of long-term debt |
RepaymentsOfLongTermDebt
|
$9.08M | USD | 2 Qtrs |
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions |
ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions
|
$97.37M | USD | 2 Qtrs |
| Payments of initial public offering costs |
PaymentsOfStockIssuanceCosts
|
$1.98M | USD | 2 Qtrs |
| Proceeds from issuance of long-term debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
$33.44M | USD | 2 Qtrs |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$10.00K | USD | 2 Qtrs |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$21.00K | USD | 2 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$24.38M | USD | 2 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$95.40M | USD | 2 Qtrs |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$125.00K | USD | 2 Qtrs |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-13.00K | USD | 2 Qtrs |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$22.50M | USD | 2 Qtrs |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$27.00M | USD | 2 Qtrs |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$12.44M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.74M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$47.74M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$34.94M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$12.44M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.74M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$47.74M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$34.94M | USD | Point-in-time |
| Reclassification of warrant liability to equity upon initial public offering |
ReclassificationOfWarrantLiabilityToEquityUponInitialPublicOffering
|
$-1.24M | USD | 2 Qtrs |
| Transfers of inventory to property and equipment |
InventoryTransferToPropertyPlantAndEquipment
|
$1.26M | USD | 2 Qtrs |
| Transfers of inventory to property and equipment |
InventoryTransferToPropertyPlantAndEquipment
|
$994.00K | USD | 2 Qtrs |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
$19.00K | USD | 2 Qtrs |
| Offering costs included in accounts payable and accrued expenses |
OfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
$1.38M | USD | 2 Qtrs |
Stockholders Equity
41 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Discounts and issuance costs of stock issued |
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
$5.97M | USD | 1 Quarter |
| Balance |
StockholdersEquity
|
$-199.04M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-168.72M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-179.66M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-192.24M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-173.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$71.16M | USD | Point-in-time |
| Conversion of convertible preferred stock into common stock upon initial public offering |
StockIssuedDuringPeriodValueConversionOfUnits
|
$186.52M | USD | 1 Quarter |
| Conversion of preferred stock warrants into common stock warrants upon initial public offering |
ConversionOfPreferredStockWarrantsIntoCommonStockWarrantsUponInitialPublicOffering
|
$1.24M | USD | 1 Quarter |
| Issuance of common stock in initial public offering, net of discounts and issuance costs of $5,966 |
StockIssuedDuringPeriodValueNewIssues
|
$91.40M | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$12.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$6.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$8.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$9.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$220.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$34.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$57.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$27.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-6.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$13.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-21.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$34.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-8.00K | USD | 2 Qtrs |
| Unrealized gains on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$4.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$7.00K | USD | 2 Qtrs |
| Unrealized gains on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$3.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$30.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$30.00K | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-6.12M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.89M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.20M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-11.02M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-4.90M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-16.09M | USD | 2 Qtrs |
| Balance |
StockholdersEquity
|
$-199.04M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-168.72M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-179.66M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-192.24M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-173.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$71.16M | USD | Point-in-time |
Comprehensive Income
25 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-6.12M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.89M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.20M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-11.02M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-4.90M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-16.09M | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-6.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$13.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-21.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$34.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-8.00K | USD | 2 Qtrs |
| Unrealized gains on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$4.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$7.00K | USD | 2 Qtrs |
| Unrealized gains on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$3.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$30.00K | USD | 1 Quarter |
| Unrealized gains on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$30.00K | USD | 2 Qtrs |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$43.00K | USD | 2 Qtrs |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-1.00K | USD | 2 Qtrs |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$1.00K | USD | 1 Quarter |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$9.00K | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-11.02M | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-6.11M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-16.05M | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-9.19M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.